Active	Status	Sponsor type	Region	Phase	Filter
2 Active 0 Inactive 2 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
zhang, zizhen
NCT05769725: A Study to Evaluate Serplulimab in Combination With Docetaxel +S-1 VS. Docetaxel +S-1 as Adjuvant Treatment Therapy in Stage IIIc Gastric Cancer	Recruiting	2	70	RoW	Serplulimab, HLX10, Docetaxel, S1	RenJi Hospital	Serplulimab,Gastric Cancer, Adjuvant Therapy	03/25	03/26
NCT05555901: The Efficacy and Safety of Fruquintinib Plus Chemotherapy as Second-line Treatment in Metastatic Colorectal Cancer	Recruiting	2	116	RoW	Fruquintinib+ chemotherapy, Bevacizumab+ chemotherapy	Fudan University	Metastatic Colorectal Cancer	09/25	09/25